Accelerating the Journey to Decarbonization
As the 25th largest carbon-emitter in the world, the biotechnology and pharmaceutical sector must accelerate its decarbonization efforts now to preserve a livable climate and achieve net-zero GHG emissions by 2050.
This won't be easy to do. The biotechnology and pharmaceutical sector faces daunting challenges to decarbonization. And, in a lot of ways, carbon reduction and the stringent environmental conditioning necessary for the sector to minimize microbial load and ensure safety and quality can be opposing forces.
The good news is that there are technologies available today that can safely replace nearly 50% of the fossil fuels the sector uses for electricity and manufacturing processes.
Our presentation focuses on specific steps the biotechnology and pharmaceutical sector can take now to reduce Scope 1 and 2 emissions and prepare for a net-zero carbon emissions future.
- Learn the challenges the biotechnology and pharmaceutical sector faces in achieving net-zero carbon emissions;
- Learn about the technologies available today that can safely replace nearly 50% of the fossil fuels the sector uses for electricity and manufacturing processes;
- Learn about the steps the sector must take now to prepare for a net-zero carbon emissions future; and
- Learn how Millig Design Build is helping a world leader in scientific technology and pharmaceuticals reduce greenhouse gas emissions across its operations.
Colton Heaps, PE, LEED AP BD+C, is Director of Engineering at Millig Design Build. Colton has 15 years of experience developing design-build retrofit projects nationwide. Colton is currently responsible for leading a diverse team of engineering talent and ensuring the precision and quality of Millig Design Build efforts.
Lauren co-founded Millig Design Build, an integrated engineering, design, and construction firm specializing in industrial decarbonization. As its vice president, Lauren works in partnership with clients to achieve organizational energy transformation.
Note: Abstracts and biographies are displayed as submitted by the author(s) with the exception of minor edits for style, grammar consistency, and length.